원발성 간암의 신생물딸림증후군으로 표현된 다발성근염과 횡문근융해
Polymyositis and Rhabdomyolysis as Paraneoplastic Manifestations of Primary Liver Cancer
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
다발성근염은 사지 근위부의 골격근을 대칭적으로 침범하는 원인불명의 자가면역 질환으로, 악성종양과 동반된 사례가 보고되고 있으나 피부 근염에 비해 드물다. 이에 혼합 간세포-담관상피암종으로 추정되는 원발성 간암의 신생물딸림증후군에 의한 횡문근융해와 다발성근염 1예를 경험하여 보고하는 바이다.
Abstract
Polymyositis is characterized by symmetrical proximal muscle weakness, nonsuppurative inflammation of skeletal muscle, elevation of muscle enzyme levels, and abnormality of electromyographical change. Its pathogenesis is unclear. Paraneoplastic syndromes are caused by malignant tumors, although not through direct effects of the primary tumor or its metastases. Several paraneoplastic syndromes, including erythrocytosis, hypoglycemia, and hypercholesterolemia, have been reported in patients with hepatocellular carcinoma. A few cases of polymyositis associated with hepatocellular carcinoma and one case of combined hepatocellular-cholangiocarcinoma associated with polymyositis and chronic hepatitis B virus infection have been reported. Skeletal muscle injuries without trauma, including metabolic myopathy, effects of certain drugs and toxins, infection, electrolyte imbalances, and endocrine disorders, may cause rhabdomyolysis. We present here a case of primary liver cancer associated with polymyositis and rhabdomyolysis.
참고문헌 (19)
- 정혜진, "다발성근염과 만성 B형 간염에 병발한 혼합 간세포-담관상피암종 1예", 대한내과학회지, 72(1), pp.79~84 (2007), 대한내과학회
- Stertz G., "Polymyositis", Berl Klin Wochenschr, 53, pp.489~ (1916)
- Callen JP, "The relationship of dermatomyositis and polymyositis to internal malignancy", Arch Dermatol, 116, pp.295~298 (1980)
- Carpenter S, "Inclusion body myositis: a distinct variety of idiopathic inflammatory myopathy", Neurology, 28, pp.8~17 (1978)
- Bohan A, "Polymyositis and dermatomyositis (first of two parts)", N Engl J Med, 292, pp.344~347 (1975)
- Bezechy R., "Dermatomyositis. 1st ed" (1986), McGraw-Hill
- Dawkins RL, "Cell-mediated cytotoxicity to muscle in polymyositis: effect of immunosuppression", N Engl J Med, 288, pp.434~438 (1973)
- Grace JT Jr, "Dermatomyositis in cancer: a possible etiological mechanism", Cancer, 12, pp.648~650 (1959)
- Alexander S, "Dermatomyositis and carcinoma: a case report and immunological investigation", Br J Dermatol, 80, pp.86~89 (1968)
- Hasegawa K, "Polymyositis as a paraneoplastic manifestation of hepatocellular carcinoma", Hepatogastroenterology, 47, pp.1425~1427 (2000)
- Kim PH, "Three cases of polymyositis developed associated with chronic liver disease", Korean J Med, 56, pp.418~426 (1999)
- Sigurgeirsson B, "Risk of cancer in patients with dermatomyositis or polymyositis: a population-based study", N Engl J Med, 326, pp.363~367 (1992)
- Stockton D, "Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study", Br J Cancer, 85, pp.41~45 (2001)
- Hill CL, "Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study", Lancet, 357, pp.96~100 (2001)
- Lee HY, "A case dermatomyositis associated with adenocarcinoma of stomach", Korean J Med, 31, pp.708~714 (1986)
- Yong SJ, "A case of polymyositis associated with epidermoid carcinoma of lung", Korean J Med, 32, pp.678~684 (1987)
- Joffe MM, "Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy", Am J Med, 94, pp.379~387 (1993)
- Moriguchi M, "Kashiwazaki S. Intravenous immunoglobulin therapy for refractory myositis", Intern Med, 35, pp.663~667 (1996)
- The Liver Cancer Study Group of Japan, "Primary liver cancer in Japan. report 7th", Acta Heparol Jpn, 27, pp.1161~1169 (1986)